Change Agents

Change Agents

Software
Avalon Globocare Corp is an intelligent biotech developer and healthcare service provider dedicated to promoting and empowering high-impact, transformative biotechnology, clinical applications, and healthcare facility management. The company has two reportable segments: the real property operating segment, which is the key revenue driver, and the laboratory testing services segment. The company focuses on diagnostic and therapeutic areas like early detection of oral cancer, ovarian cancer, kidney cancer, skin regeneration and anti-fibrosis, and treatments of degenerative disorders.

$2.3M

Market Cap • 10/9/2026

2014

(12 years)

Founded

2016

(10 years ago)

IPO

NASDAQ

Listing Exchange

Flag of United States

United States

Country

Valuation

P/B

0

P/S

—

P/EBITDA

—

P/OCF

—

P/FCF

—

P/E

—

BVPS

109,5

EPS

—

Market Cap

Market Cap

2,3M

EV

20,9M

EV/Revenue

0

EV/EBITDA

-3,8

EV/EBIT

-3,1

Payout

Dividend Per Share

0

Dividend Yield

0%

Buyback Yield

-164,6%

Total Yield

-164,6%

Payout

0%

Retained Earnings

6,6K

Profitability

Gross Margin

—

EBITDA Margin

—

EBIT Margin

—

Net Margin

—

D&A/EBITDA

0%

R&D/Revenue

0%

Capex/Revenue

0%

Capex/D&A

0%

Capex/OCF

0%

SBC/OCF

—

% PPE

1%

% Goodwill

87%

ROE

—

ROIC

—

Growth

CAGR Revenue 5Y

-100%

CAGR Op. Income 5Y

-9,2%

CAGR Net Income 5Y

24,4%

CAGR EPS 5Y

-59,1%

CAGR OCF 5Y

-3,8%

Leverage

N.D./EBITDA

—

Debt/Equity

0%

Current Ratio

0,1

Quick Ratio

0

Interest Coverage

—

Premium

Unlock 100% of the data and have immediate access on more than 6.000 companies with updated information!
  • Unrestricted access
  • Unlimited data history
  • Analysis videos
  • Quarterly highlights
  • Customizable financials table
  • Ranking
  • Discussions

...and much more!

Get Premium